We are live on ! Find out more
KFP

Keystone Financial Planning Portfolio holdings

AUM $388M
1-Year Est. Return 16.66%
This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+16.66%
3 Year Est. Return
+34.06%
5 Year Est. Return
+32.93%
10 Year Est. Return
+97.12%
AUM
$345M
AUM Growth
+$676K
Cap. Flow
-$3.44M
Cap. Flow %
-1%
Top 10 Hldgs %
75.81%
Holding
48
New
2
Increased
7
Reduced
27
Closed
4

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$8.71M
2
PM icon
Philip Morris
PM
+$8.13M
3
AMGN icon
Amgen
AMGN
+$194K
4
DEO icon
Diageo
DEO
+$46.3K
5
PEG icon
Public Service Enterprise Group
PEG
+$13.6K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$10.4M
2
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$3.07M
3
HLN icon
Haleon
HLN
+$1.6M
4
SOLV icon
Solventum
SOLV
+$1.14M
5
WBD icon
Warner Bros
WBD
+$930K

Sector Composition

Rank Sector Weight
1 Financials 11.77%
2 Consumer Staples 11.66%
3 Technology 6.99%
4 Healthcare 5.64%
5 Energy 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$618B
$1.98M 0.57%
9,569
-67
-0.7% -$13.2K
T icon
27
AT&T
T
$159B
$1.58M 0.46%
63,513
-301
-0.5% -$7.62K
PG icon
28
Procter & Gamble
PG
$336B
$1.29M 0.38%
9,021
– –
PNW icon
29
Pinnacle West Capital
PNW
$12.2B
$1.16M 0.34%
13,126
-133
-1% -$11.9K
SNY icon
30
Sanofi
SNY
$103B
$1.07M 0.31%
22,016
+172
+0.8% +$8.53K
LMT icon
31
Lockheed Martin
LMT
$134B
$930K 0.27%
1,923
– –
CL icon
32
Colgate-Palmolive
CL
$73.1B
$701K 0.2%
8,875
– –
TJX icon
33
TJX Companies
TJX
$174B
$650K 0.19%
4,228
+11
+0.3% +$1.63K
EMR icon
34
Emerson Electric
EMR
$83.9B
$608K 0.18%
4,582
– –
HLN icon
35
Haleon
HLN
$43.5B
$550K 0.16%
54,366
-168,476
-76% -$1.6M
VNQ icon
36
Vanguard Real Estate ETF
VNQ
$39.2B
$437K 0.13%
4,942
– –
PEG icon
37
Public Service Enterprise Group
PEG
$38.2B
$434K 0.13%
5,406
+167
+3% +$13.6K
CVS icon
38
CVS Health
CVS
$133B
$359K 0.1%
4,521
– –
BAC icon
39
Bank of America
BAC
$435B
$323K 0.09%
5,881
– –
VTRS icon
40
Viatris
VTRS
$20.4B
$316K 0.09%
25,402
-481
-2% -$5.19K
VYM icon
41
Vanguard High Dividend Yield ETF
VYM
$80.9B
$310K 0.09%
2,159
-25
-1% -$3.56K
ACN icon
42
Accenture
ACN
$102B
$291K 0.08%
1,085
– –
GSK icon
43
GSK
GSK
$104B
$228K 0.07%
4,652
-222,804
-98% -$10.4M
AMGN icon
44
Amgen
AMGN
$208B
$200K 0.06%
+612
New +$194K
K
45
DELISTED
Kellanova
K
– –
-8,756
Closed -$718K
TD icon
46
Toronto Dominion Bank
TD
$198B
– –
-4,104
Closed -$328K
WBD icon
47
Warner Bros
WBD
$65.9B
– –
-47,638
Closed -$930K
SOLV icon
48
Solventum
SOLV
$14.8B
– –
-15,554
Closed -$1.14M
1
2

Similar funds

PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return
AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $390M AUM 16.72% 1-Year Est. Return
P8IP
Pier 88 Investment Partners San Francisco, California $390M AUM 10.13% 1-Year Est. Return

Keystone Financial Planning's Q4 2025 Portfolio in Review

As of Q4 2025, Keystone Financial Planning held 48 positions worth $345M, up 0.2% from $344M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Keystone Financial Planning's Q4 2025 filing shows 2 new, 7 increased, 27 reduced and 4 closed positions. Its largest new stake was CME Group: 32,041 shares worth $8.75M. The largest sale was GSK, an estimated $10.4M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 8.8% a quarter earlier, followed by Consumer Staples and Technology.

  • Keystone Financial Planning's largest Q4 2025 buy was CME Group: 32,041 shares worth $8.75M.
  • Keystone Financial Planning added most to Philip Morris in Q4 2025, an estimated $8.13M increase.
  • Keystone Financial Planning's biggest Q4 2025 reduction was GSK, cutting an estimated $10.4M.
  • Keystone Financial Planning fully exited Solventum in Q4 2025, selling an estimated $1.14M.
  • Keystone Financial Planning's ten largest holdings make up 76% of its $345M portfolio in Q4 2025.
  • Keystone Financial Planning opened 2 new positions and closed 4 in Q4 2025.
  • Keystone Financial Planning's portfolio value rose 0.2% quarter-over-quarter to $345M.

Based on Keystone Financial Planning's 13F filing for Q4 2025, filed 7 Jan 2026.